ASAQ is considered the result of an innovative partnership because:

  • Multiple actors from developed and developing countries collaborated within DNDi‘s FACT Project to develop ASAQ with public funding
  • Sanofi-aventis, (now: Sanofi) the world’s fourth-largest pharmaceutical company, agreed to produce ASAQ at cost and without patent